Iovance Biotherapeutics, Inc. Common Stock Repurchased for the Trailing 12 Months (TTM) ending March 31, 2025: USD 0.00

Iovance Biotherapeutics, Inc. Common Stock Repurchased is USD 0.00 for the Trailing 12 Months (TTM) ending March 31, 2025, a -100.00% change year over year. Common stock repurchased is cash used to buy back the company’s own shares from the market.
  • Iovance Biotherapeutics, Inc. Common Stock Repurchased for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -301.00 K, a -88.64% change year over year.
  • Iovance Biotherapeutics, Inc. Common Stock Repurchased for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -2.65 M, a -267.02% change year over year.
  • Iovance Biotherapeutics, Inc. Common Stock Repurchased for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.59 M, a -158,700.00% change year over year.
  • Iovance Biotherapeutics, Inc. Common Stock Repurchased for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -1.00 K, a -99.72% change year over year.
Key Data
Date Common Stock Repurchased Free Cash Flow Operating Cash Flow Capital Expenditure